Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients

British Journal of Nutrition

Volumn 106, Issue 3, 2011, Pages 383-389

  Brasnyó, Pál ^a   Molnár, Gergo A ^a   Mohás, Márton ^a   Markó, Lajos ^a   Laczy, Boglárka ^a   Cseh, Judit ^a   Mikolás, Esztella ^a   Szijártó, István András ^a   Mérei, Ákos ^a   Halmai, Richárd ^a   Mészáros, László G ^b   Sümegi, Balázs ^a   Wittmann, István ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b Life Sciences Foundation   (United States)

Author keywords

Akt; Insulin sensitivity; Oxidative stress; Resveratrol; Type 2 diabetes

Indexed keywords

3 (2 HYDROXYPHENYL)ALANINE; ANGIOTENSIN RECEPTOR ANTAGONIST; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FRUCTOSAMINE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INCRETIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; POLYPHENOL; PROTEIN KINASE B; RESVERATROL; TRIACYLGLYCEROL; 2 TYROSINE; 2-TYROSINE; PLANT EXTRACT; STILBENE DERIVATIVE; TYROSINE;

ADULT; ARTICLE; B LYMPHOCYTE; BLOOD ANALYSIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; ENZYME ACTIVATION; FRUCTOSAMINE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PROTEIN PHOSPHORYLATION; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL; URINALYSIS; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PHYTOTHERAPY; SIGNAL TRANSDUCTION; THROMBOCYTE; URINE;

ADULT; BLOOD PLATELETS; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT EXTRACTS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STILBENES; TYROSINE;

EID: 80052910300     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114511000316     Document Type: Article

References (32)

1. Renaud S & de Lorgeril M (1992) Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339, 1523-1526.
2. Goldfinger TM (2003) Beyond the French paradox: the impact of moderate beverage alcohol and wine consumption in the prevention of cardiovascular disease. Cardiol Clin 21, 449-457. (Pubitemid 37356493)
3. Cucciolla V, Borriello A, Oliva A, et al. (2007) Resveratrol: from basic science to the clinic. Cell Cycle 6, 2495-2510. (Pubitemid 350058668)
4. Silan C (2008) The effects of chronic resveratrol treatment on vascular responsiveness of streptozotocin-induced diabetic rats. Biol Pharm Bull 31, 897-902. (Pubitemid 351731986)
5. Ray PS, Maulik G, Cordis GA, et al. (1999) The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. Free Radic Biol Med 27, 160-169. (Pubitemid 29353096)
6. Palfi A, Bartha E, Copf L, et al. (2009) Alcohol-free red wine inhibits isoproterenol-induced cardiac remodeling in rats by the regulation of Akt1 and protein kinase C alpha/beta II. J Nutr Biochem 20, 418-425.
7. Wallerath T, Deckert G, Ternes T, et al. (2002) Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 106, 1652-1658.
8. Poussier B, Cordova AC, Becquemin JP, et al. (2005) Resveratrol inhibits vascular smooth muscle cell proliferation and induces apoptosis. J Vasc Surg 42, 1190-1197.
9. Radnai B, Tucsek Z, Bognar Z, et al. (2009) Ferulaldehyde, a water-soluble degradation product of polyphenols, inhibits the lipopolysaccharide-induced inflammatory response in mice. J Nutr 139, 291-297.
10. Delbosc S, Paizanis E, Magous R, et al. (2005) Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance, the fructose-fed rat. Atherosclerosis 179, 43-49. (Pubitemid 40249784)
11. Houstis N, Rosen ED & Lander ES (2006) Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440, 944-948.
12. Wei Y, Whaley-Connell AT, Chen K, et al. (2007) NADPH oxidase contributes to vascular inflammation, insulin resistance, and remodeling in the transgenic (mRen2) rat. Hypertension 50, 384-391. (Pubitemid 47205789)
13. Evans JL, Maddux BA & Goldfine ID (2005) The molecular basis for oxidative stress-induced insulin resistance. Antioxid Redox Signal 7, 1040-1052. (Pubitemid 40967154)
14. Baynes JW (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40, 405-412.
15. Rüweler M, Gülden M, Maser E, et al. (2009) Cytotoxic, cytoprotective and antioxidant activities of resveratrol and analogues in C6 astroglioma cells in vitro. Chem Biol Interact 182, 128-135.
16. Bhavnani BR, Cecutti A, Gerulath A, et al. (2001) Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E and probucol on low-density lipoprotein oxidation in postmenopausal women. Menopause 8, 408-419. (Pubitemid 33111576)
17. Sharma S, Anjaneyulu M, Kulkarni SK, et al. (2006) Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats. Pharmacology 76, 69-75. (Pubitemid 43131538)
18. Kumar A, Kaundal RK, Iyer S, et al. (2007) Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy. Life Sci 80, 1236-1244. (Pubitemid 46329013)
19. Cockcroft DW & Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16, 31-41.
20. Nagaretani H, Nakamura T, Funahashi T, et al. (2001) Visceral fat is a major contributor for multiple risk factor clustering in Japanese men with impaired glucose tolerance. Diabetes Care 24, 2127-2133. (Pubitemid 33716533)
21. Matthews DR, Hosker JP, Rudenski AS, et al. (1985) Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419. (Pubitemid 15018832)
22. Stumvoll M, Mitrakou A, Pimenta W, et al. (2000) Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23, 295-301. (Pubitemid 30131733)
23. Molnár GA, Wagner Z, Markó L, et al. (2005) Urinary orthotyrosine excretion in diabetes mellitus and renal failure: evidence for hydroxyl radical production. Kidney Int 68, 2281-2287. (Pubitemid 43117805)
24. Wagner L, Laczy B, Tamaskó M, et al. (2007) Cigarette smoke-induced alterations in endothelial nitric oxide synthase phosphorylation: role of protein kinase C. Endothelium 4, 245-255. (Pubitemid 47553512)
25. Chan WH (2005) Effect of resveratrol on high glucoseinduced stress in human leukemia K562 cells. J Cell Biochem 94, 1267-1279.
26. Yen GC, Duh PD & Lin CW (2003) Effects of resveratrol and 4-hexylresorcinol on hydrogen peroxide-induced oxidative DNA damage in human lymphocytes. Free Radic Res 37, 509-514.
27. Kanauchi M, Kimura K, Akai Y, et al. (2004) Insulin resistance and pancreatic beta-cell function in patients with hypertensive kidney disease. Nephrol Dial Transplant 19, 2025-2029. (Pubitemid 39139633)
28. Thirunavukkarasu M, Penumathsa SV, Koneru S, et al. (2007) Resveratrol alleviates cardiac dysfunction in streptozotocininduced diabetes: role of nitric oxide, thioredoxin, and heme oxygenase. Free Radic Biol Med 43, 720-729. (Pubitemid 47102122)
29. Rivera L, Morón R, Zarzuelo A, et al. (2009) Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochem Pharmacol 77, 1053-1063.
30. Avogaro A, de Kreutzenberg SV & Fadini GP (2008) Oxidative stress and vascular disease in diabetes: is the dichotomization of insulin signaling still valid? Free Radic Biol Med 44, 1209-1215.
31. Baur JA & Sinclair DA (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5, 493-506. (Pubitemid 44136961)
32. Perdew GH, Hollingshead BD, Dinatale BC, et al. (2010) Estrogen receptor expression is required for low-dose resveratrol-mediated repression of aryl hydrocarbon receptor activity. J Pharmacol Exp Ther 335, 273-283.